| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/11/2023 | LISATA THERAPEUTICS, INC. | CLBS | Payment of Exercise | Common Stock | 1k | $3.20 | $3.3k | | 01/11/2023 |
| 01/10/2023 | LISATA THERAPEUTICS, INC. | CLBS | Payment of Exercise | Common Stock | 3.5k | $3.20 | $11.1k | | 01/09/2023 |
| 01/09/2023 | LISATA THERAPEUTICS, INC. | CLBS | Payment of Exercise | Common Stock | 7.8k | $3.00 | $23.5k | | 01/09/2023 |
| 01/09/2023 | LISATA THERAPEUTICS, INC. | CLBS | Grant | Common Stock | 60k | $0.00 | $0 | | 01/09/2023 |
| 01/09/2023 | LISATA THERAPEUTICS, INC. | CLBS | Grant | Stock Options (Right to Buy) | 30k | $3.00 | $90k | | 01/09/2023 |
| 01/14/2022 | LISATA THERAPEUTICS, INC. | CLBS | Payment of Exercise | Common Stock | 6.6k | $0.82 | $5.4k | | 01/13/2022 |
| 01/13/2022 | LISATA THERAPEUTICS, INC. | CLBS | Payment of Exercise | Common Stock | 6.5k | $0.81 | $5.2k | | 01/13/2022 |
| 01/11/2022 | LISATA THERAPEUTICS, INC. | CLBS | Payment of Exercise | Common Stock | 16.7k | $0.87 | $14.5k | | 01/10/2022 |
| 01/10/2022 | LISATA THERAPEUTICS, INC. | CLBS | Grant | Stock Option (Right to Buy) | 200k | $0.92 | $183.4k | | 01/10/2022 |
| 01/10/2022 | LISATA THERAPEUTICS, INC. | CLBS | Payment of Exercise | Common Stock | 56.4k | $0.92 | $51.7k | | 01/10/2022 |
| 01/10/2022 | LISATA THERAPEUTICS, INC. | CLBS | Grant | Common Stock | 401k | $0.00 | $0 | | 01/10/2022 |
| 04/01/2021 | PALISADE BIO, INC. | CUR | Grant | | 6k | $0.00 | $0 | | 04/01/2021 |
| 01/14/2021 | LISATA THERAPEUTICS, INC. | CLBS | Payment of Exercise | Common Stock | 5.9k | $1.56 | $9.3k | | 01/13/2021 |
| 01/13/2021 | LISATA THERAPEUTICS, INC. | CLBS | Grant | Common Stock | 39k | $0.00 | $0 | | 01/13/2021 |
| 01/13/2021 | LISATA THERAPEUTICS, INC. | CLBS | Payment of Exercise | Common Stock | 21.8k | $1.55 | $33.8k | | 01/13/2021 |
| 01/13/2021 | LISATA THERAPEUTICS, INC. | CLBS | Payment of Exercise | Common Stock | 6.4k | $1.55 | $10k | | 01/13/2021 |
| 01/11/2021 | LISATA THERAPEUTICS, INC. | CLBS | Grant | Common Stock | 119k | $0.00 | $0 | | 01/08/2021 |
| 01/11/2021 | LISATA THERAPEUTICS, INC. | CLBS | Payment of Exercise | Common Stock | 16.6k | $1.59 | $26.4k | | 01/08/2021 |
| 01/11/2021 | LISATA THERAPEUTICS, INC. | CLBS | Grant | Stock Options (Right to Buy) | 60k | $1.59 | $95.4k | | 01/08/2021 |
| 01/08/2021 | LISATA THERAPEUTICS, INC. | CLBS | Payment of Exercise | Common Stock | 4.7k | $1.60 | $7.6k | | 01/08/2021 |
| 04/03/2020 | PALISADE BIO, INC. | CUR | Grant | | 6k | $0.00 | $0 | | 04/03/2020 |
| 02/28/2020 | EyePoint Pharmaceuticals, Inc. | EYPT | Grant | Restricted Stock Units | 19k | $0.00 | $0 | | 02/28/2020 |
| 02/28/2020 | EyePoint Pharmaceuticals, Inc. | EYPT | Grant | Stock Option (Right to Buy) | 33.5k | $1.29 | $43.2k | | 02/28/2020 |
| 01/14/2020 | LISATA THERAPEUTICS, INC. | CLBS | Payment of Exercise | Common Stock | 6.4k | $3.38 | $21.6k | | 01/13/2020 |
| 01/13/2020 | LISATA THERAPEUTICS, INC. | CLBS | Payment of Exercise | Common Stock | 6.2k | $3.28 | $20.5k | | 01/13/2020 |
| 01/13/2020 | LISATA THERAPEUTICS, INC. | CLBS | Grant | Common Stock | 46k | $0.00 | $0 | | 01/13/2020 |
| 01/13/2020 | LISATA THERAPEUTICS, INC. | CLBS | Grant | Stock Options (Right to Buy) | 69k | $3.28 | $226.3k | | 01/13/2020 |
| 01/08/2020 | LISATA THERAPEUTICS, INC. | CLBS | Payment of Exercise | Common Stock | 4.5k | $2.83 | $12.8k | | 01/08/2020 |
| 10/09/2019 | EyePoint Pharmaceuticals, Inc. | EYPT | Exercise | Stock Option (Right to Buy) | 33.3k | $1.95 | $65k | | 10/09/2019 |
| 09/06/2019 | EyePoint Pharmaceuticals, Inc. | EYPT | Exercise | Deferred Stock Unit | 417 | $0.00 | $0 | | 09/06/2019 |
| 07/01/2019 | PALISADE BIO, INC. | CUR | Grant | | 10.1k | $0.00 | $0 | | 07/01/2019 |
| 07/01/2019 | PALISADE BIO, INC. | CUR | Grant | | 187.5k | $0.30 | $56.3k | | 07/01/2019 |
| 06/25/2019 | EyePoint Pharmaceuticals, Inc. | EYPT | Grant | Stock Option (Right to Buy) | 40k | $2.65 | $106k | | 06/25/2019 |
| 06/21/2019 | EyePoint Pharmaceuticals, Inc. | EYPT | Exercise | Deferred Stock Units | 8.3k | $0.00 | $0 | | 06/21/2019 |
| 03/29/2019 | EyePoint Pharmaceuticals, Inc. | EYPT | Exercise | Stock Option (Right to Buy) | 20k | $1.77 | $35.4k | | 03/29/2019 |
|